5083-84-1

5083-84-1 structure
5083-84-1 structure
  • Name: Norisoboldine hydrochloride
  • Chemical Name: Norisoboldine hydrochloride
  • CAS Number: 5083-84-1
  • Molecular Formula: C18H20ClNO4
  • Molecular Weight: 349.81
  • Catalog: Signaling Pathways GPCR/G Protein Adenosine Receptor
  • Create Date: 2021-09-27 13:52:46
  • Modify Date: 2024-01-11 17:50:03
  • Norisoboldine hydrochloride is an orally active natural aryl hydrocarbon receptor (AhR) agonist. Norisoboldine hydrochloride, as a major isoquinoline alkaloid present in Radix Linderae, can be used for the research of Rheumatoid arthritis and Ulcerative colitis[1][2].

Name Norisoboldine hydrochloride
Description Norisoboldine hydrochloride is an orally active natural aryl hydrocarbon receptor (AhR) agonist. Norisoboldine hydrochloride, as a major isoquinoline alkaloid present in Radix Linderae, can be used for the research of Rheumatoid arthritis and Ulcerative colitis[1][2].
Related Catalog
Target

AhR[2]

In Vitro Norisoboldine hydrochloride (1~30 μM; 0~24 hours; CD4+T cells) activates AhR under hypoxic microenvironment and significantly downregulates mRNA expression of miR-31[2]. Norisoboldine hydrochloride (30 μM; 0~24 hours; CD4+T cells) inhibits glycolysis in hypoxia[2]. Norisoboldine hydrochloride (1~30 μM; 0~72 hours; Treg cells) promotes Treg differentiation in hypoxia[2]. Norisoboldine hydrochloride (10, 30 μM) facilitates the disassociation of HSP90/AhR complexes, the nuclear translocation of AhR, and the formation of AhR/ARNT complexes. Norisoboldine hydrochloride induces generation of Treg cells in hypoxia[2]. Western Blot Analysis[2] Cell Line: CD4+T cells Concentration: 1~30 μM Incubation Time: 24 hours Result: Activated AhR in cells under hypoxic microenvironment. RT-PCR[2] Cell Line: CD4+T cells Concentration: 1~30 μM Incubation Time: 24 hours Result: Significantly downregulated mRNA expression of miR-31. Immunofluorescence[2] Cell Line: CD4+T cells Concentration: 30 μM Incubation Time: 24 hours Result: Inhibited glycolysis in hypoxia. Immunofluorescence[2] Cell Line: Treg cells Concentration: 1~30 μM Incubation Time: 72 hours Result: Promoted Treg differentiation in hypoxia.
In Vivo Norisoboldine hydrochloride (10~40 mg/kg; p.o.; 20 days) significantly reduces the severity of joint swelling and erythema during the course of the experiment[1]. Norisoboldine hydrochloride (40 mg/kg; i.g.; 10 days) induces enhancement of CYP1A1 expression and suppresses expressions of Glut1 and HK2 in colons[2]. Animal Model: Male ICR mice (18–22 g) Dosage: 10~40 mg/kg Administration: P.o. Result: Significantly reduced the severity of joint swelling and erythema during the course of the experiment. Animal Model: Female C57BL/6 mice (18–22 g) Dosage: 40 mg/kg Administration: I.g. Result: Induced enhancement of CYP1A1 expression and suppressed expressions of Glut1 and HK2 in colons.
References

[1]. Luo Y, et al. Therapeutic effect of norisoboldine, an alkaloid isolated from Radix Linderae, on collagen-induced arthritis in mice. Phytomedicine. 2010;17(10):726-731.

[2]. Lv Q, et al. Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD+/SIRT1/SUV39H1/H3K9me3 signaling pathway. Cell Death Dis. 2018;9(3):258. Published 2018 Feb 15.

Molecular Formula C18H20ClNO4
Molecular Weight 349.81
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.